Australia Stock Exchange release from CARDIEX : New Clinical Trial with Andwin, Syneos & Philip Morris
13/02/2022 22:42
Australia Stock Exchange release from CARDIEX CDX.AX : New Clinical Trial with Andwin, Syneos & Philip Morris
Recent news on Conneqt Health
See all newsAustralia's CONNEQT Health set for biggest weekly gain in 11 months on US distribution deal
Australia's CONNEQT Health extends gains on deal with US-based Blueprint
Australia's Conneqt Health gains most in over 5-months on U.S. distribution deal
Brief: Conneqt Health Enters Commercial Marketing Agreement With Blueprint
Brief: Conneqt Health Posts FY Net Loss Of A$10.86 Million